FDA Approves Rapid-Acting Insulin, Lyumjev, for Pump Use FDA Approves Rapid-Acting Insulin, Lyumjev, for Pump Use

Approved for diabetes treatment last year, it ' s the second ultra-rapid-acting insulin approved for use in insulin delivery devices.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Alert Source Type: news